|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Profit for the year | |||||
| Adjustments to reconcile profit for the year to net cash generated from operating activities: | |||||
| Gain on sale of property, plant and equipment, net | |||||
| Depreciation, amortization and impairment expense | |||||
| Unrealized exchange (gain)/loss, net | |||||
| Share-based compensation expense | |||||
| Share of net (profit)/loss of associates accounted for using equity method | |||||
| Share of net (profit)/loss of associate and joint venture accounted for using equity method | |||||
| Income tax expense | |||||
| Finance and other income, net of finance expenses | |||||
| (Gain)/loss from sale of business and investment accounted for using the equity method | |||||
| Change in fair value of contingent consideration | |||||
| Lifetime expected credit loss/(write-back) | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities; net of effects from acquisitions | |||||
| (Increase)/Decrease in trade receivables | |||||
| (Increase)/Decrease in unbilled receivables and contract assets | |||||
| (Increase)/Decrease in Inventories | |||||
| Other assets | |||||
| Trade payables, accrued expenses, other liabilities and provisions | |||||
| Increase)/Decrease in other financial assets and other assets | |||||
| Increase/(Decrease) in trade payables, accrued expenses, other financial liabilities, other liabilities and provisions | |||||
| Increase/(Decrease) in contract liabilities | |||||
| Cash generated from operating activities before taxes | |||||
| Income taxes paid, net | |||||
| Net cash generated from operating activities | |||||
| Cash flows from investing activities: | |||||
| Payment for purchase of property, plant and equipment | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Investment in associate | |||||
| Payment for purchase of investments | |||||
| Proceeds from restricted interim dividend account | |||||
| Proceeds from sale of investments | |||||
| Payment for business acquisitions including deposits and escrow, net of cash acquired | |||||
| Payment for investment in joint venture | |||||
| Proceeds from sale of business, net of cash | |||||
| Proceeds from sale of investment accounted for using the equity method | |||||
| Proceeds from/(repayment of) security deposit for property, plant and equipment | |||||
| Interest received | |||||
| Dividend received | |||||
| Net cash generated from/(used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of equity shares and shares pending allotment | |||||
| Repayment of loans and borrowings | |||||
| Proceeds from loans and borrowings | |||||
| Payment of lease liabilities including interests | |||||
| Payment for buyback of equity shares, including tax and transaction cost | |||||
| Payment for contingent consideration | |||||
| Payment of deferred consideration on business combination | |||||
| Interest and finance expenses paid | |||||
| Payment of dividend | |||||
| Payment of dividend to Non-controlling interests holders | |||||
| Net cash generated from/(used in) financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents during the year | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
Loading...
